These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 27689198

  • 21. Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation.
    Stravitz RT, Reuben A, Mizrahi M, Lalazar G, Brown K, Gordon SC, Ilan Y, Sanyal A.
    J Hepatol; 2015 Dec; 63(6):1345-51. PubMed ID: 26220750
    [Abstract] [Full Text] [Related]

  • 22. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [Abstract] [Full Text] [Related]

  • 23. A good prognostic predictor for liver transplantation recipients with benign end-stage liver cirrhosis.
    Wei Q, Nemdharry RS, Zhuang RZ, Li J, Ling Q, Wu J, Shen T, Zhou L, Xie HY, Zhang M, Xu X, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):164-168. PubMed ID: 28381380
    [Abstract] [Full Text] [Related]

  • 24. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A, Giannini E, Botta F, Romagnoli P, Risso D, Celle G, Testa R.
    Hepatogastroenterology; 2000 Apr; 47(31):234-8. PubMed ID: 10690614
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma.
    Limquiaco JL, Wong GL, Wong VW, Lai PB, Chan HL.
    J Gastroenterol Hepatol; 2009 Jan; 24(1):63-9. PubMed ID: 19054256
    [Abstract] [Full Text] [Related]

  • 26. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R.
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [Abstract] [Full Text] [Related]

  • 27. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis.
    Zipprich A, Kuss O, Rogowski S, Kleber G, Lotterer E, Seufferlein T, Fleig WE, Dollinger MM.
    Gut; 2010 Jul; 59(7):963-8. PubMed ID: 20581243
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G, Lotterer E, Link I, Hahn EG, Fleig WE.
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [Abstract] [Full Text] [Related]

  • 33. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis.
    Merkel C, Bolognesi M, Bellon S, Bianco S, Honisch B, Lampe H, Angeli P, Gatta A.
    Gut; 1992 Jun; 33(6):836-42. PubMed ID: 1624169
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Value of MELD and MELD-based indices in surgical risk evaluation of cirrhotic patients: retrospective analysis of 190 cases.
    Costa BP, Sousa FC, Serôdio M, Carvalho C.
    World J Surg; 2009 Aug; 33(8):1711-9. PubMed ID: 19513784
    [Abstract] [Full Text] [Related]

  • 36. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R.
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [Abstract] [Full Text] [Related]

  • 37. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.
    Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R.
    Gut; 2003 Jan; 52(1):134-9. PubMed ID: 12477775
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
    Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD.
    Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.